HeartBeam Inc BEAT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
-
HeartBeam Reports First Quarter 2026 Results
-
HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic
-
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice
-
HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time
-
HeartBeam Announces Closing of $10 Million Public Offering of Common Stock
-
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
-
HeartBeam Announces Proposed Public Offering of Common Stock
Trading Information
- Previous Close Price
- $0.76
- Day Range
- $0.74–0.79
- 52-Week Range
- $0.54–4.00
- Bid/Ask
- $0.75 / $0.77
- Shares Outstanding
- 55.51M
- Market Cap
- $42.06M
- Volume/Avg
- 479,685 / 980,338
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 17
- Website
- https://www.heartbeam.com
Valuation
|
Metric
|
BEAT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 48.90 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BEAT
|
|---|---|
Quick Ratio | 0.62 |
Current Ratio | 0.74 |
Interest Coverage | — |
Quick Ratio
BEAT
Profitability
|
Metric
|
BEAT
|
|---|---|
Return on Assets (Normalized) | −269.97% |
Return on Equity (Normalized) | −487.66% |
Return on Invested Capital (Normalized) | −491.57% |
Return on Assets
BEAT
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| Hcvxztvns | Sfq | $26B | |||
| BrightSpring Health Services Inc
BTSG
| — | Zbgvjk | $12B | |||
| Pro Medicus Ltd
PMCUF
| — | Jybpd | $12B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | Rnmncx | $12B | |||
| Tempus AI Inc Class A common stock
TEM
| — | Jhxp | $9B | |||
| HealthEquity Inc
HQY
| — | Fzmpfs | $7B | |||
| M3 Inc
MTHRF
| — | Tkklssl | $7B | |||
| M3 Inc ADR
MTHRY
| — | Rkjpqt | $7B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | Bqpr | $5B | |||
| Doximity Inc Class A
DOCS
| — | Zwbqdb | $4B |
United States